What is it about?
This paper discuss the process to fabricate and test emtricitabine loaded nanoparticles that could be useful for treatment or prevention of HIV.
Featured Image
Why is it important?
Long-acting HIV medicines should improve adherence to therapy (treatment or PrEP). It has been difficult to get a long-acting nano formulation of emtricitabine. This paper explains one method to accomplish this.
Perspectives
It is important to have long-acting options for HIV treatment and prevention. Having a long-acting nano formulation of emtricitabine will make long-acting parenteral treatment and prevention medicines a reality.
Dr Christopher J Destache
Creighton University
Read the Original
This page is a summary of: An Enhanced Emtricitabine-Loaded Long-Acting Nanoformulation for Prevention or Treatment of HIV Infection, Antimicrobial Agents and Chemotherapy, November 2016, ASM Journals,
DOI: 10.1128/aac.01475-16.
You can read the full text:
Contributors
The following have contributed to this page
